Somatic evolutionary timings of driver mutations
- PMID: 29347918
- PMCID: PMC5774140
- DOI: 10.1186/s12885-017-3977-y
Somatic evolutionary timings of driver mutations
Abstract
Background: A unified analysis of DNA sequences from hundreds of tumors concluded that the driver mutations primarily occur in the earliest stages of cancer formation, with relatively few driver mutation events detected in the late-arising subclones. However, emerging evidence from the sequencing of multiple tumors and tumor regions per individual suggests that late-arising subclones with additional driver mutations are underestimated in single-sample analyses.
Methods: To test whether driver mutations generally map to early tumor development, we examined multi-regional tumor sequencing data from 101 individuals reported in 11 published studies. Following previous studies, we annotated mutations as early-arising when all tumors/regions had those mutations (ubiquitous). We then inferred the fraction of mutations occurring early and compared it with late-arising mutations that were found in only single tumors/regions.
Results: While a large fraction of driver mutations in tumors occurred relatively early in cancers, later driver mutations occurred at least as frequently as the early drivers in a substantial number of patients. This result was robust to many different approaches to annotate driver mutations. The relative frequency of early and late driver mutations varied among patients of the same cancer type and in different cancer types. We found that previous reports of the preponderance of early driver mutations were primarily informed by analysis of single tumor variant allele profiles, with which it is challenging to clearly distinguish between early and late drivers.
Conclusions: The origin and preponderance of new driver mutations are not limited to early stages of tumor evolution, with different tumors and regions showing distinct driver mutations and, consequently, distinct characteristics. Therefore, tumors with extensive intratumor heterogeneity appear to have many newly acquired drivers.
Keywords: Driver mutation; Private mutation; Somatic mutation; Ubiquitous mutation.
Conflict of interest statement
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures







Similar articles
-
Cancer heterogeneity: converting a limitation into a source of biologic information.J Transl Med. 2017 Sep 8;15(1):190. doi: 10.1186/s12967-017-1290-9. J Transl Med. 2017. PMID: 28886708 Free PMC article. Review.
-
Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma.J Hepatol. 2018 Jul;69(1):89-98. doi: 10.1016/j.jhep.2018.02.029. Epub 2018 Mar 16. J Hepatol. 2018. PMID: 29551704
-
Order Matters: The Order of Somatic Mutations Influences Cancer Evolution.Cold Spring Harb Perspect Med. 2017 Apr 3;7(4):a027060. doi: 10.1101/cshperspect.a027060. Cold Spring Harb Perspect Med. 2017. PMID: 28096247 Free PMC article. Review.
-
Deciphering intratumor heterogeneity using cancer genome analysis.Hum Genet. 2016 Jun;135(6):635-42. doi: 10.1007/s00439-016-1670-x. Epub 2016 Apr 28. Hum Genet. 2016. PMID: 27126234 Review.
-
SubClonal Hierarchy Inference from Somatic Mutations: Automatic Reconstruction of Cancer Evolutionary Trees from Multi-region Next Generation Sequencing.PLoS Comput Biol. 2015 Oct 5;11(10):e1004416. doi: 10.1371/journal.pcbi.1004416. eCollection 2015 Oct. PLoS Comput Biol. 2015. PMID: 26436540 Free PMC article.
Cited by
-
The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA.Front Oncol. 2019 Sep 24;9:952. doi: 10.3389/fonc.2019.00952. eCollection 2019. Front Oncol. 2019. PMID: 31608239 Free PMC article. Review.
-
Molecular Biology and Evolution of Cancer: From Discovery to Action.Mol Biol Evol. 2020 Feb 1;37(2):320-326. doi: 10.1093/molbev/msz242. Mol Biol Evol. 2020. PMID: 31642480 Free PMC article.
-
Genome instability is associated with ethnic differences between Asians and Europeans in hepatocellular carcinoma.Theranostics. 2022 Jun 6;12(10):4703-4717. doi: 10.7150/thno.71676. eCollection 2022. Theranostics. 2022. PMID: 35832070 Free PMC article.
-
Mutplot: An easy-to-use online tool for plotting complex mutation data with flexibility.PLoS One. 2019 May 15;14(5):e0215838. doi: 10.1371/journal.pone.0215838. eCollection 2019. PLoS One. 2019. PMID: 31091262 Free PMC article.
-
Strength of selection in lung tumors correlates with clinical features better than tumor mutation burden.Sci Rep. 2024 Jun 3;14(1):12732. doi: 10.1038/s41598-024-63468-z. Sci Rep. 2024. PMID: 38831004 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources